Lipid Monitoring Guidelines

Introduction to Lipid Monitoring

The European Society of Cardiology recommends rechecking lipids 8 weeks (range 4-12 weeks) after starting or adjusting lipid-lowering therapy, then annually once at target 1, 2, 3
Obtain at least two baseline lipid measurements separated by 1-12 weeks before initiating therapy, according to the European Society of Cardiology 1, 2, 3
Exception: In acute coronary syndrome or very high-risk patients, immediate treatment without waiting for repeat measurements is appropriate, as stated by the European Society of Cardiology 1, 2, 3

Recheck lipids at 8 weeks (±4 weeks) after initiating lipid-lowering medication, as recommended by the European Society of Cardiology 1, 2, 3
Recheck lipids at 8 weeks (±4 weeks) after any dose adjustment, according to the European Society of Cardiology 1, 2, 3
The American Diabetes Association supports the 4-12 week window for patients on statins 6

For diabetes patients, follow the same schedule: lipid profile at diagnosis, then every 5 years if under age 40 and low risk, as recommended by the American Diabetes Association 6
After starting statins, recheck lipids 4-12 weeks post-initiation/dose change, then annually, according to the American Diabetes Association 6
The American Geriatrics Society recommends continuing standard monitoring schedule if already on statin therapy for older adults (>75 years) 6